Ghrelin and Obestatin in CKD Children

Plain-language summary

This observational study examined levels of the hormones ghrelin and obestatin in children with chronic kidney disease. It enrolled children who had been on hemodialysis for at least 3 months or had received a kidney transplant at least 6 months earlier, excluding those on growth hormone treatment. It was conducted as a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Azienda Ospedaliero Universitaria Maggiore della Carita

Intervention

none intervention

Start date

1/1/2013

Estimated completion

6/30/2015

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* the CKD-HD patients should have been on hemodialysis treatment for at least 3 months
* the RTx patients should have received renal transplantation at least 6 months before

Exclusion Criteria:

* treatment with growth hormone
* the presence of neurologic disability or syndromic diseases affecting per se food intake
* for controls: they should have no history of chronic diseases and should not receive any medication. They should be on unrestricted diet.